LONDON (Alliance News) - Regenerative medical devices company Tissue Regenix Group PLC on Tuesday said it has appointed the chief executive of Consort Medical PLC as a non-executive director.
Jonathan Glenn has been the CEO at Consort, an AIM-listed contract development and manufacturing company for the pharmaceutical industry, since 2007.
Shares in Tissue Regenix were up 1.1% to 13.40 pence.
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Tissue Regenix Group (TRX)